ProShares Ultra Nasdaq Biotechnology Rating $48.34 +0.43 (+0.90%) As of 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.70Holdings in BIB have an aggregate rating of Moderate Buy based on 676 analyst ratings issued in the past year covering 44 companies (55.7% of the portfolio).BIB Aggregate Price Target$48.07High Prediction$48.07Average Prediction$48.07Low Prediction$48.07Holdings in BIB have an aggregate price target of $48.07 and a range of $48.07 to $48.07 covering 44 companies (55.7% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.57%GILDGilead Sciences$111.25-0.2%4.8478 of 5 stars2.78$110.55 -0.6%27Positive NewsInsider Trade5.53%VRTXVertex Pharmaceuticals$454.64-0.5%4.673 of 5 stars2.54$511.62 12.5%28Positive News5.33%AMGNAmgen$298.25+0.5%4.273 of 5 stars2.35$307.82 3.2%23Positive News4.39%REGNRegeneron Pharmaceuticals$547.15-0.1%4.9419 of 5 stars2.80$813.57 48.7%25Trending NewsAnalyst Downgrade3.30%AZNAstraZeneca$69.44-2.4%2.313 of 5 stars2.83$85.00 22.4%6Positive News2.94%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3098 of 5 stars2.79$340.00 2.4%24Analyst Forecast1.48%BIIBBiogen$132.74-0.3%4.9596 of 5 stars2.38$188.48 42.0%321.45%INSMInsmed$98.50+0.3%4.5855 of 5 stars3.00$106.80 8.4%171.42%ARGXargenex$543.32-0.3%4.3225 of 5 stars3.05$728.06 34.0%21Analyst Forecast1.23%SMMTSummit Therapeutics$24.40+7.9%2.4956 of 5 stars2.79$34.67 42.1%14Analyst ForecastOptions VolumeTrading HaltedHigh Trading Volume1.21%RPRXRoyalty Pharma$36.35+0.4%4.9236 of 5 stars3.25$47.33 30.2%4Positive News1.20%ILMNIllumina$100.40+0.1%4.8817 of 5 stars2.47$127.39 26.9%19Positive News1.08%SNYSanofi$48.89-0.9%4.3776 of 5 stars3.11$61.50 25.8%9Analyst Forecast1.06%INCYIncyte$68.46+0.4%4.3767 of 5 stars2.22$74.53 8.9%18Trending News1.03%UTHRUnited Therapeutics$294.57-0.2%4.9963 of 5 stars2.69$386.15 31.1%13Positive NewsAnalyst Forecast0.99%NBIXNeurocrine Biosciences$129.09-0.2%4.9405 of 5 stars2.86$162.00 25.5%220.95%EXELExelixis$45.91+3.6%4.7471 of 5 stars2.52$43.56 -5.1%21Positive NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.90%TEMTempus AI$60.78+2.7%2.2325 of 5 stars2.54$63.67 4.7%13Analyst Forecast0.85%VTRSViatris$9.25-1.0%3.2626 of 5 stars1.80$10.40 12.4%50.85%BNTXBioNTech$109.65+1.3%2.5154 of 5 stars2.83$137.86 25.7%18Gap Down0.85%BMRNBioMarin Pharmaceutical$57.25+0.1%4.9287 of 5 stars2.75$93.61 63.5%24Positive NewsAnalyst Forecast0.84%ASNDAscendis Pharma A/S$174.07+0.6%3.5656 of 5 stars3.00$220.67 26.8%15Analyst Forecast0.84%MRNAModerna$30.46+0.6%4.3872 of 5 stars2.04$46.61 53.0%23Options Volume0.80%ONCBeOne Medicines$245.49+0.5%3.5487 of 5 stars3.00$320.67 30.6%6Gap Up0.72%MEDPMedpace$321.50-1.4%4.4597 of 5 stars2.21$344.82 7.3%140.68%BBIOBridgeBio Pharma$43.71+2.0%4.7148 of 5 stars2.93$58.85 34.6%14News CoverageAnalyst ForecastInsider TradeAnalyst Revision0.66%BPMCBlueprint Medicines$128.27+0.1%1.5615 of 5 stars2.27$128.06 -0.2%220.62%ROIVRoivant Sciences$10.99+0.1%1.9578 of 5 stars3.00$17.50 59.3%40.59%VRNAVerona Pharma PLC American Depositary Share$91.18+1.2%2.5915 of 5 stars3.00$107.36 17.7%12Positive NewsAnalyst Forecast0.55%RVMDRevolution Medicines$37.00-0.5%4.516 of 5 stars3.00$67.58 82.7%12Analyst Revision0.53%JAZZJazz Pharmaceuticals$109.45-0.4%4.9353 of 5 stars2.92$184.00 68.1%13Positive News0.53%MDGLMadrigal Pharmaceuticals$298.49-0.6%3.9865 of 5 stars2.89$420.63 40.9%90.52%HALOHalozyme Therapeutics$53.45-0.7%4.8192 of 5 stars2.17$61.90 15.8%12Analyst Revision0.51%IONSIonis Pharmaceuticals$42.98-1.4%4.6113 of 5 stars2.78$58.25 35.5%18News CoverageAnalyst Upgrade0.50%GHGuardant Health$50.13-0.1%3.6529 of 5 stars3.00$53.76 7.3%21Insider Trade0.42%NUVLNuvalent$80.37-0.2%3.7504 of 5 stars3.17$119.60 48.8%12Analyst UpgradeInsider Trade0.41%AXSMAxsome Therapeutics$105.36+1.4%4.6796 of 5 stars3.06$172.33 63.6%16Analyst ForecastAnalyst Revision0.38%ALKSAlkermes$28.75-0.9%4.9199 of 5 stars2.83$40.00 39.1%12News CoveragePositive NewsAnalyst Revision0.36%AKROAkero Therapeutics$51.66-0.4%3.6442 of 5 stars3.00$82.50 59.7%60.35%ADMAADMA Biologics$18.12-0.1%4.2095 of 5 stars3.33$27.67 52.7%30.34%PCVXVaxcyte$33.24-0.1%1.821 of 5 stars3.10$136.50 310.7%10News CoveragePositive News0.33%CRSPCRISPR Therapeutics$52.16+0.9%2.9873 of 5 stars2.53$71.75 37.6%170.32%RYTMRhythm Pharmaceuticals$65.78-1.7%3.8176 of 5 stars3.00$77.31 17.5%130.32%KRYSKrystal Biotech$143.01+1.2%4.559 of 5 stars3.00$211.13 47.6%9News CoverageAnalyst Revision This page (NASDAQ:BIB) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
